Baker Bros. Capital (GP), LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Bros. Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Bros. Capital (GP), LLC. Baker Bros. Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in Diadexus, Inc. ($DDXS) and 10% Owner in ADOLOR CORP ($ADLR) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Latest Insider Trading Transactions of Baker Bros. Capital (GP), LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, IBPI, AUXL, BCRX, DDXS, GHDX, HRTX, INCY, SGEN, GEVA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31 2012 | DDXS | Diadexus, Inc. | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 0.22 | 59,340 | 13,156 | 0 | 59.3 K to 0 (-100.00 %) |
| Jan 20 2012 | DDXS | Diadexus, Inc. | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 0.20 | 20,000 | 4,000 | 59,340 | 79.3 K to 59.3 K (-25.21 %) |
| Jan 20 2012 | DDXS | Diadexus, Inc. | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 0.21 | 118,800 | 25,233 | 79,340 | 198.1 K to 79.3 K (-59.96 %) |
| Jan 04 2012 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Option Exercise | X | 6.25 | 68,006 | 425,038 | 0 | |
| Jan 04 2012 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | X | 6.25 | 68,006 | 425,038 | 539,130 | 471.1 K to 539.1 K (+14.43 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Bros. Capital (GP), LLC | Director | Grant | A | 0.00 | 474 | 0 | 220,692 | 220.2 K to 220.7 K (+0.22 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Bros. Capital (GP), LLC | Director | Grant | A | 0.00 | 76,484 | 0 | 220,218 | 143.7 K to 220.2 K (+53.21 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Bros. Capital (GP), LLC | Director | Grant | A | 0.00 | 77,141 | 0 | 143,734 | 66.6 K to 143.7 K (+115.84 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Bros. Capital (GP), LLC | Director | Grant | A | 0.00 | 5,292 | 0 | 66,593 | 61.3 K to 66.6 K (+8.63 %) |
| Jul 05 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Bros. Capital (GP), LLC | Director | Sell | J | 0.00 | 9,852 | 0 | 306,508 | 316.4 K to 306.5 K (-3.11 %) |
| Jul 05 2011 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Sell | J | 0.00 | 10,766 | 0 | 471,124 | 481.9 K to 471.1 K (-2.23 %) |
| Jul 05 2011 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Sell | J | 0.00 | 11,664 | 0 | 227,594 | 239.3 K to 227.6 K (-4.88 %) |
| Jul 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Sell | J | 0.00 | 7,280 | 0 | 187,135 | 194.4 K to 187.1 K (-3.74 %) |
| Jul 05 2011 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 9,590 | 0 | 62,407 | 72 K to 62.4 K (-13.32 %) |
| Jul 05 2011 | IBPI | Ardea Biosciences, ... | Baker Bros. Capital (GP), LLC | Director | Sell | J | 0.00 | 9,301 | 0 | 126,709 | 136 K to 126.7 K (-6.84 %) |
| Jul 05 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 6,992 | 0 | 0 | 7 K to 0 (-100.00 %) |
| Jul 05 2011 | HRTX | HERON THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Option Exercise | J | 1,000.00 | 600 | 600,000 | 0 | |
| Jul 05 2011 | HRTX | HERON THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Option Exercise | J | 0.04 | 300 | 12 | 0 | |
| Jul 05 2011 | HRTX | HERON THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 1,786 | 0 | 0 | 1.8 K to 0 (-100.00 %) |
| Jul 05 2011 | ADLR | ADOLOR CORP | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 2,902 | 0 | 0 | 2.9 K to 0 (-100.00 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 26.35 | 1 | 26 | 194,415 | 194.4 K to 194.4 K (0.00 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 26.30 | 3 | 79 | 194,414 | 194.4 K to 194.4 K (0.00 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 26.25 | 45 | 1,181 | 194,411 | 194.4 K to 194.4 K (+0.02 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 26.10 | 7 | 183 | 194,366 | 194.4 K to 194.4 K (0.00 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 26.11 | 5 | 131 | 194,359 | 194.4 K to 194.4 K (0.00 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 26.15 | 15 | 392 | 194,354 | 194.3 K to 194.4 K (+0.01 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 26.14 | 16 | 418 | 194,339 | 194.3 K to 194.3 K (+0.01 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 26.17 | 27 | 707 | 194,323 | 194.3 K to 194.3 K (+0.01 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 27.51 | 21 | 578 | 194,296 | 194.3 K to 194.3 K (+0.01 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 27.47 | 23 | 632 | 194,275 | 194.3 K to 194.3 K (+0.01 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 27.48 | 22 | 605 | 194,252 | 194.2 K to 194.3 K (+0.01 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 27.46 | 12 | 330 | 194,230 | 194.2 K to 194.2 K (+0.01 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 27.04 | 34 | 919 | 194,218 | 194.2 K to 194.2 K (+0.02 %) |
Page: 1